Advertisement
Screener

ADMA BIOLOGICS, INC. (ADMA) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

ADMA BIOLOGICS, INC. Stock-Based Compensation

ADMA BIOLOGICS, INC. (ADMA) reported Stock-Based Compensation of $6.13 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-05

  • ADMA BIOLOGICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $6.13M, a 23.61% increase year-over-year.
  • ADMA BIOLOGICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $6.33M, a 36.87% increase year-over-year.
  • ADMA BIOLOGICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $5.39M, a 0.75% decline year-over-year.
  • ADMA BIOLOGICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $5.05M, a 58.76% increase year-over-year.
  • ADMA BIOLOGICS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $20.03M, a 47.08% increase from fiscal 2024.
  • ADMA BIOLOGICS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $13.62M, a 120.07% increase from fiscal 2023.
  • ADMA BIOLOGICS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $6.19M, a 18.64% increase from fiscal 2022.
  • ADMA BIOLOGICS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $5.21M, a 49.51% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 3 month as first filedShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 6 month as first filedShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 9 month as first filedShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 12 month as first filed
2026-06-30$6.13M
10-Q · filed 2026-08-05
$12.46M
10-Q · filed 2026-08-05
$17.86M
derived: sum of 3 quarters · filed 2026-08-05
$22.90M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$6.33M
10-Q · filed 2026-05-06
$11.72M
derived: sum of 2 quarters · filed 2026-05-06
$16.77M
derived: sum of 3 quarters · filed 2026-05-06
$21.73M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$5.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$10.44M
derived: sum of 2 quarters · filed 2026-02-25
$15.40M
derived: sum of 3 quarters · filed 2026-08-05
$20.03M
10-K · filed 2026-02-25
2025-09-30$5.05M
10-Q · filed 2025-11-05
$10.01M
derived: sum of 2 quarters · filed 2026-08-05
$14.63M
10-Q · filed 2025-11-05
$20.07M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$4.96M
10-Q · filed 2026-08-05
$9.59M
10-Q · filed 2026-08-05
$15.02M
derived: sum of 3 quarters · filed 2026-08-05
$18.20M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$4.62M
10-Q · filed 2026-05-06
$10.06M
derived: sum of 2 quarters · filed 2026-05-06
$13.24M
derived: sum of 3 quarters · filed 2026-05-06
$16.10M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$5.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$8.61M
derived: sum of 2 quarters · filed 2026-02-25
$11.47M
derived: sum of 3 quarters · filed 2026-02-25
$13.62M
10-K · filed 2026-02-25
2024-09-30$3.18M
10-Q · filed 2025-11-05
$6.04M
derived: sum of 2 quarters · filed 2025-11-05
$8.18M
10-Q · filed 2025-11-05
$9.93M
derived: sum of 4 quarters · filed 2026-02-25
2024-06-30$2.86M
10-Q · filed 2025-08-06
$5.00M
10-Q · filed 2025-08-06
$6.75M
derived: sum of 3 quarters · filed 2026-02-25
$8.44M
derived: sum of 4 quarters · filed 2026-02-25
2024-03-31$2.14M
10-Q · filed 2025-05-07
$3.89M
derived: sum of 2 quarters · filed 2026-02-25
$5.58M
derived: sum of 3 quarters · filed 2026-02-25
$7.22M
derived: sum of 4 quarters · filed 2026-02-25
2023-12-31$1.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$3.44M
derived: sum of 2 quarters · filed 2026-02-25
$5.08M
derived: sum of 3 quarters · filed 2026-02-25
$6.19M
10-K · filed 2026-02-25
2023-09-30$1.70M
10-Q · filed 2024-11-07
$1.69M
10-Q · filed 2023-11-08
$3.33M
derived: sum of 2 quarters · filed 2024-11-07
$4.44M
10-Q · filed 2024-11-07
$4.44M
10-Q · filed 2023-11-08
$5.51M
derived: sum of 4 quarters · filed 2025-03-18
2023-06-30$1.64M
10-Q · filed 2024-08-08
$1.64M
10-Q · filed 2023-08-09
$2.75M
10-Q · filed 2024-08-08
$2.75M
10-Q · filed 2023-08-09
$3.82M
derived: sum of 3 quarters · filed 2025-03-18
$5.13M
derived: sum of 4 quarters · filed 2025-03-18
2023-03-31$1.11M
10-Q · filed 2024-05-09
$1.11M
10-Q · filed 2023-05-10
$2.18M
derived: sum of 2 quarters · filed 2025-03-18
$3.49M
derived: sum of 3 quarters · filed 2025-03-18
$4.68M
derived: sum of 4 quarters · filed 2025-03-18
2022-12-31$1.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18
$2.38M
derived: sum of 2 quarters · filed 2025-03-18
$3.57M
derived: sum of 3 quarters · filed 2025-03-18
$5.21M
10-K · filed 2025-03-18
$5.21M
10-K · filed 2023-03-23
2022-09-30$1.31M
10-Q · filed 2023-11-08
$2.50M
derived: sum of 2 quarters · filed 2023-11-08
$4.15M
10-Q · filed 2023-11-08
$5.36M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30$1.19M
10-Q · filed 2023-08-09
$2.83M
10-Q · filed 2023-08-09
$4.05M
derived: sum of 3 quarters · filed 2024-02-28
$4.73M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31$1.64M
10-Q · filed 2023-05-10
$2.85M
derived: sum of 2 quarters · filed 2024-02-28
$3.54M
derived: sum of 3 quarters · filed 2024-02-28
$4.35M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31$1.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$1.90M
derived: sum of 2 quarters · filed 2024-02-28
$2.71M
derived: sum of 3 quarters · filed 2024-02-28
$3.49M
10-K · filed 2024-02-28
$3.49M
10-K · filed 2022-03-24
2021-09-30$688.27K
10-Q · filed 2022-11-09
$1.49M
derived: sum of 2 quarters · filed 2022-11-09
$2.27M
10-Q · filed 2022-11-09
$2.96M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$805.19K
10-Q · filed 2022-08-10
$1.59M
10-Q · filed 2022-08-10
$2.27M
derived: sum of 3 quarters · filed 2022-08-10
$3.05M
derived: sum of 4 quarters · filed 2022-08-10
2021-03-31$781.40K
10-Q · filed 2022-05-11
$1.47M
derived: sum of 2 quarters · filed 2022-05-11
$2.24M
derived: sum of 3 quarters · filed 2022-05-11
$2.96M
derived: sum of 4 quarters · filed 2022-05-11
2020-12-31$688.18K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24
$1.46M
derived: sum of 2 quarters · filed 2022-03-24
$2.18M
derived: sum of 3 quarters · filed 2022-03-24
$2.86M
10-K · filed 2022-03-24
2020-09-30$774.78K
10-Q · filed 2021-11-10
$1.49M
derived: sum of 2 quarters · filed 2021-11-10
$2.17M
10-Q · filed 2021-11-10
$2.80M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30$715.61K
10-Q · filed 2021-08-11
$1.39M
10-Q · filed 2021-08-11
$2.03M
derived: sum of 3 quarters · filed 2021-08-11
$2.68M
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31$676.55K
10-Q · filed 2021-05-12
$1.31M
derived: sum of 2 quarters · filed 2021-05-12
$1.96M
derived: sum of 3 quarters · filed 2021-05-12
$2.69M
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31$636.11K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25
$1.29M
derived: sum of 2 quarters · filed 2021-03-25
$2.01M
derived: sum of 3 quarters · filed 2021-03-25
$2.65M
10-K · filed 2021-03-25
2019-09-30$650.67K
10-Q · filed 2020-11-05
$1.38M
derived: sum of 2 quarters · filed 2020-11-05
$2.01M
10-Q · filed 2020-11-05
$2.61M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30$726.74K
10-Q · filed 2020-08-05
$1.36M
10-Q · filed 2020-08-05
$1.96M
derived: sum of 3 quarters · filed 2020-08-05
$2.54M
derived: sum of 4 quarters · filed 2020-08-05
2019-03-31$637.26K
10-Q · filed 2020-05-06
$1.23M
derived: sum of 2 quarters · filed 2020-05-06
$1.81M
derived: sum of 3 quarters · filed 2020-05-06
$2.35M
derived: sum of 4 quarters · filed 2020-05-06
2018-12-31$595.53K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
$1.17M
derived: sum of 2 quarters · filed 2020-03-13
$1.71M
derived: sum of 3 quarters · filed 2020-03-13
$2.22M
10-K · filed 2020-03-13
2018-09-30$577.58K
10-Q · filed 2019-11-06
$1.11M
derived: sum of 2 quarters · filed 2019-11-06
$1.63M
10-Q · filed 2019-11-06
$2.14M
derived: sum of 4 quarters · filed 2019-11-06
2018-06-30$535.39K
10-Q · filed 2019-08-08
$1.05M
10-Q · filed 2019-08-08
$1.56M
derived: sum of 3 quarters · filed 2019-08-08
$2.06M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31$514.78K
10-Q · filed 2019-05-08
$1.02M
derived: sum of 2 quarters · filed 2019-05-08
$1.53M
derived: sum of 3 quarters · filed 2019-05-08
$1.84M
derived: sum of 4 quarters · filed 2019-05-08
2017-12-31$508.69K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13
$1.01M
derived: sum of 2 quarters · filed 2019-03-13
$1.33M
derived: sum of 3 quarters · filed 2019-03-13
$1.56M
10-K · filed 2019-03-13
2017-09-30$505.73K
10-Q · filed 2018-11-09
$817.09K
derived: sum of 2 quarters · filed 2018-11-09
$1.05M
10-Q · filed 2018-11-09
$1.31M
derived: sum of 4 quarters · filed 2018-11-09
2017-06-30$311.36K
10-Q · filed 2018-08-10
$547.24K
10-Q · filed 2018-08-10
$801.23K
derived: sum of 3 quarters · filed 2018-08-10
$1.06M
derived: sum of 4 quarters · filed 2018-08-10
2017-03-31$235.88K
10-Q · filed 2018-05-14
$489.86K
derived: sum of 2 quarters · filed 2018-05-14
$752.83K
derived: sum of 3 quarters · filed 2018-05-14
$1.06M
derived: sum of 4 quarters · filed 2018-05-14
2016-12-31$253.99K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29
$516.95K
derived: sum of 2 quarters · filed 2018-03-29
$827.89K
derived: sum of 3 quarters · filed 2018-03-29
$1.25M
10-K · filed 2018-03-29
2016-09-30$262.96K
10-Q · filed 2017-11-03
$573.91K
derived: sum of 2 quarters · filed 2017-11-03
$996.09K
10-Q · filed 2017-11-03
$1.49M
derived: sum of 4 quarters · filed 2017-11-03
2016-06-30$310.94K
10-Q · filed 2017-08-11
$733.13K
10-Q · filed 2017-08-11
$1.22M
derived: sum of 3 quarters · filed 2017-08-11
$1.67M
derived: sum of 4 quarters · filed 2017-08-11
2016-03-31$422.18K
10-Q · filed 2017-05-12
$911.57K
derived: sum of 2 quarters · filed 2017-05-12
$1.36M
derived: sum of 3 quarters · filed 2017-05-12
$1.75M
derived: sum of 4 quarters · filed 2017-05-12
2015-12-31$489.38K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24
$937.32K
derived: sum of 2 quarters · filed 2017-02-24
$1.32M
derived: sum of 3 quarters · filed 2017-02-24
$1.71M
10-K · filed 2017-02-24
2015-09-30$447.93K
10-Q · filed 2016-11-10
$834.59K
derived: sum of 2 quarters · filed 2016-11-10
$1.22M
10-Q · filed 2016-11-10
$1.55M
derived: sum of 4 quarters · filed 2016-11-10
2015-06-30$386.66K
10-Q · filed 2016-08-12
$773.73K
10-Q · filed 2016-08-12
$1.10M
derived: sum of 3 quarters · filed 2016-08-12
$1.43M
derived: sum of 4 quarters · filed 2016-08-12
2015-03-31$387.07K
10-Q · filed 2016-05-13
$714.13K
derived: sum of 2 quarters · filed 2016-05-13
$1.04M
derived: sum of 3 quarters · filed 2016-05-13
$1.40M
derived: sum of 4 quarters · filed 2016-05-13
2014-12-31$327.06K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23
$654.12K
derived: sum of 2 quarters · filed 2016-03-23
$1.01M
derived: sum of 3 quarters · filed 2016-03-23
$1.25M
10-K · filed 2016-03-23
2014-09-30$327.06K
10-Q · filed 2015-11-10
$687.19K
derived: sum of 2 quarters · filed 2015-11-10
$921.39K
10-Q · filed 2015-11-10
$1.14M
derived: sum of 4 quarters · filed 2015-11-10
2014-06-30$360.13K
10-Q · filed 2015-08-11
$594.33K
10-Q · filed 2015-08-11
$816.09K
derived: sum of 3 quarters · filed 2015-08-11
$1.04M
derived: sum of 4 quarters · filed 2015-08-11
2014-03-31$234.20K
10-Q · filed 2015-05-12
$455.96K
derived: sum of 2 quarters · filed 2015-05-12
$681.18K
derived: sum of 3 quarters · filed 2015-05-12
$903.95K
derived: sum of 4 quarters · filed 2015-05-12
2013-12-31$221.76K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09
$446.98K
derived: sum of 2 quarters · filed 2015-03-09
$669.75K
derived: sum of 3 quarters · filed 2015-03-09
$888.29K
10-K · filed 2015-03-09
2013-09-30$225.22K
10-Q · filed 2014-11-10
$447.99K
derived: sum of 2 quarters · filed 2014-11-10
$666.54K
10-Q · filed 2014-11-10
$884.78K
derived: sum of 4 quarters · filed 2014-11-10
2013-06-30$222.77K
10-Q · filed 2014-08-11
$441.31K
10-Q · filed 2014-08-11
$659.56K
derived: sum of 3 quarters · filed 2014-08-11
$867.75K
derived: sum of 4 quarters · filed 2014-08-11
2013-03-31$218.54K
10-Q · filed 2014-05-12
$436.79K
derived: sum of 2 quarters · filed 2014-05-12
$644.98K
derived: sum of 3 quarters · filed 2014-05-12
$799.08K
derived: sum of 4 quarters · filed 2014-05-12
2012-12-31$218.24K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28
$426.44K
derived: sum of 2 quarters · filed 2014-03-28
$580.53K
derived: sum of 3 quarters · filed 2014-03-28
$626.79K
10-K · filed 2014-03-28
2012-09-30$208.19K
10-Q · filed 2013-11-12
$362.29K
derived: sum of 2 quarters · filed 2013-11-12
$408.54K
10-Q · filed 2013-11-12
$411.87K
derived: sum of 4 quarters · filed 2013-11-12
2012-06-30$154.09K
10-Q · filed 2013-08-12
$200.35K
10-Q · filed 2013-08-12
$203.67K
derived: sum of 3 quarters · filed 2013-08-12
$206.29K
derived: sum of 4 quarters · filed 2013-08-12
2012-03-31$46.25K
10-Q · filed 2013-05-14
$49.58K
derived: sum of 2 quarters · filed 2013-05-14
$52.20K
derived: sum of 3 quarters · filed 2013-05-14
$59.59K
derived: sum of 4 quarters · filed 2013-05-14
2011-12-31$3.32K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-06
$5.94K
derived: sum of 2 quarters · filed 2013-03-06
$13.34K
derived: sum of 3 quarters · filed 2013-03-06
$22.95K
10-K · filed 2013-03-06
2011-09-30$2.62K
10-Q · filed 2012-11-13
$10.01K
derived: sum of 2 quarters · filed 2012-11-13
$19.62K
10-Q · filed 2012-11-13
2011-06-30$7.39K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14
$18.60K
10-Q · filed 2012-08-14
2011-03-31$11.20K
10-Q · filed 2012-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Greenland Mines Ltd (GRML)United States$2.362B
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
NOVAVAX INC (NVAX)United States$1.748B-6.26
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43